MICHAEL BATTLE: Open Payments
NPI 1306607387 · FISHERSVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$71 in 3 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $173 · 2025 $71
Food & beverage: $71
| Company | Payments | Amount |
|---|---|---|
| Celltrion USA Inc. | 1 | $28 |
| Janssen Biotech, Inc. | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
Products named: VEGZELMA, TREMFYA, XIFAXAN.
Industry payments across VA — which companies pay providers there.
